By N. Nefarius. Florida Atlantic University.
Cover image from 1900 calendar produced by the Antikamnia (“Opposed to Pain”) Chemical Company of St buy cabergoline 0.25mg otc breast cancer quotes of encouragement. Countering the Problem of Falsified and Substandard Drugs “Knowing is not enough; we must apply cabergoline 0.25 mg without a prescription menstrual cycle 50 days. Countering the Problem of Falsified and Substandard Drugs The National Academy of Sciences is a private cheap cabergoline 0.25mg fast delivery menstrual napkins, nonproft purchase cabergoline 0.5mg free shipping womens health hagerstown md, self-perpetuating society of distinguished scholars engaged in scientifc and engineering research, dedicated to the furtherance of science and technology and to their use for the general welfare. Upon the authority of the charter granted to it by the Congress in 1863, the Acad- emy has a mandate that requires it to advise the federal government on scientifc and technical matters. The National Academy of Engineering was established in 1964, under the charter of the National Academy of Sciences, as a parallel organization of outstanding engi- neers. It is autonomous in its administration and in the selection of its members, sharing with the National Academy of Sciences the responsibility for advising the federal government. The National Academy of Engineering also sponsors engineer- ing programs aimed at meeting national needs, encourages education and research, and recognizes the superior achievements of engineers. The Institute of Medicine was established in 1970 by the National Academy of Sciences to secure the services of eminent members of appropriate professions in the examination of policy matters pertaining to the health of the public. The Insti- tute acts under the responsibility given to the National Academy of Sciences by its congressional charter to be an adviser to the federal government and, upon its own initiative, to identify issues of medical care, research, and education. The National Research Council was organized by the National Academy of Sci- ences in 1916 to associate the broad community of science and technology with the Academy’s purposes of furthering knowledge and advising the federal government. Functioning in accordance with general policies determined by the Academy, the Council has become the principal operating agency of both the National Academy of Sciences and the National Academy of Engineering in providing services to the government, the public, and the scientifc and engineering communities. The Council is administered jointly by both Academies and the Institute of Medicine. Countering the Problem of Falsified and Substandard Drugs Copyright © National Academy of Sciences. Countering the Problem of Falsified and Substandard Drugs Reviewers This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council’s Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the institution in making its published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The review comments and draft manuscript remain confdential to protect the integrity of the deliberative process. We wish to thank the following individuals for their review of this report: Georges Benjamin, American Public Health Association Martha Brumfeld, Martha A. The review of this report was overseen by Harold Fallon, Medical University of South Carolina, and Elaine Larson, School of Nursing and Mailman School of Public Health, Columbia University. Appointed by the National Research Council and the Institute of Medicine, they were respon- sible for making certain that an independent examination of this report was carried out in accordance with institutional procedures and that all review comments were carefully considered. Responsibility for the fnal content of this report rests entirely with the authoring committee and the institution. Countering the Problem of Falsified and Substandard Drugs Acknowledgments This report is a product of the cooperation and contributions of many people. The committee and staff are especially grateful to Danielle Turnipseed and Livia Navon for their work on the manuscript, and to Deepali Patel and Susan McCutchen for their fast and accurate refer- ence review. The project ran smoothly because of the contributions of Jim Banihashemi, Sarah Ziegenhorn, Laura Harbold DeStefano, Anne Claiborne, and Vilija Teel of the Institute of Medicine. Janice Mehler of the Report Review Committee oversaw a careful peer review of the manuscript. Many experts outside of the Academies helped the committee and staff with this project. Bryan Liang of the University of California, San Diego, was not able to serve on the committee but contributed to the frst meeting. Members of the committee and staff traveled to Brasília, Delhi, Ge- neva, Hyderabad, London, and São Paulo, during this project. The committee is grateful to the following participants who spoke at meetings and helped staff plan agendas: Martin Harvey Allchurch Laurie Garrett P. Gaugh Amir Attaran Debora Germano Martin Auton Raj Shankar Ghosh Sunil Bahl Ashif Gogo Roger Bate Antony Raj Gomes Ilisa Bernstein Subhash Gouda Katherine Bond L. Goyal Regina Brown Wendy Greenall Gian Luca Burci Jeffery Gren Claudio Henrique Cabral Catherine Hill-Herndon Nicholas Cappuccino Meghana Inamdar Ranjan Chakrabarti Mariaou Tala Jallow Ranjit Chaudhury Kees de Joncheere Lim Chin Chin Connie Jung John Clark Mohga Kamal-Yanni Charles Clift Harparkash Kaur David Cockburn Sabine Kopp Emer Cooke Alan Leather Ediná Alves Costa Jamie Love Alan Coukell Rohit Malpani Elize Massard da Fonseca Paola Manchisini Filipe Soares Quirino da Silva Linda Marks Ashok Dang Sylvia Meek Joelle Daviaud Mayira Milano Leandro Teixeira de Morais Bejon Misra Jenifer Devine Archna Mudgal Pritu Dhalaria Koduru Surendra Nath Albinus D’Sa Paul Newton Douglas Duarte Fernando Nogueira Paul Ellis Doroteia Koparanova Ollivier Frederico Benite Filho Arun Panda Michele Forzley Sharon Peacock Odile Frank Patrícia Oliveira Pereira Copyright © National Academy of Sciences. Countering the Problem of Falsified and Substandard Drugs Copyright © National Academy of Sciences. Countering the Problem of Falsified and Substandard Drugs Copyright © National Academy of Sciences. Countering the Problem of Falsified and Substandard Drugs Summary The adulteration and fraudulent manufacture of medicines1 is an old problem, vastly aggravated by modern manufacturing and trade. In the last decade, impotent antimicrobial drugs have compromised the treat- ment of many deadly diseases in poor countries. More recently, negligent production at a Massachusetts compounding pharmacy sickened hundreds of Americans. While the national drugs regulatory authority (hereafter, the regulatory authority) is responsible for the safety of a country’s drug supply, no single country can entirely guarantee this today. Illegitimate2 drugs are an international problem, and there is wide consensus that action depends on international cooperation. Productive international discourse has been stymied, however, by dis- agreement about how to frame the problem. The once common use of the term counterfeit to describe any drug that is not what it claims to be is at the heart of the argument. In a narrow, legal sense, a counterfeit drug is one that infringes on a registered trademark. Some generic drug companies and civil society groups object to calling bad medicines counterfeit, seeing it as the deliberate confation of public health and in- tellectual property concerns. This report accepts the narrow meaning of counterfeit, and, because the nuances of trademark infringement must be 1 The terms medicine, drug, and pharmaceutical are used interchangeably in this report in accordance with the defnitions listed in the American Heritage Stedman’s Medical Dictionary. The trade in illegitimate drugs is, however, a problem of public health consequence and the topic of this report. In order to discuss this problem more precisely, the report distinguishes two main categories of poor-quality drugs. First, there are substandard drugs, those that do not meet the specif- cations given in the accepted pharmacopeia or in the manufacturer’s dossier. The other main category of illegitimate products is falsifed drugs, those that carry a false representation of identity or source or both. Many coun- tries also have problems with unregistered medicines, those not granted market authorization in a country. Unregistered drugs may be of good quality, though some research indicates they often are not. Unregistered medicines usually circulate outside the controlled distribution chain and are therefore suspect. The drug failures of public health concern can be divided into two main categories: falsifed and substandard. Falsifed drugs are usually also sub- standard; national specifcations referenced in the defnition of a substan- dard drug can vary. International endorsement of these two categories could advance public discourse on the topic. Recommendation 1-1: The World Health Assembly should adopt def- nitions consistent with the following principles.
Do Not Use for Weight may be substituted for the word Reduction in Such Diets Without Medical "puncture" in the warning required by Supervision discount 0.25 mg cabergoline amex women's health big book of exercises review. Do (2) The warning required by para- not use in diets supplying less than 400 Cal- graph (b)(1) of this section is not re- ories per day without medical supervision order 0.25 mg cabergoline free shipping menstruation clots. In case of nently and conspicuously on the infor- accidental overdose buy 0.5mg cabergoline with visa women's health vs fitness magazine, call a doctor or poison mation panel or principal display panel control center immediately buy discount cabergoline 0.25 mg on-line pregnancy constipation. I (4–1–10 Edition) (ii) Any beverage containing juice nism" is the most resistant microorga- where neither the juice ingredient nor nism of public health significance that the beverage has been processed in the is likely to occur in the juice. If this statement appears provided that for juice that has not on the inside of the lid, the words been processed in the manner described "Keep Refrigerated" must appear on in paragraph (g)(7) of this section, the the principal display panel or informa- lack of such processing is disclosed in tion panel. Under the act, the (2) A detailed description of the facts agency can enforce the food mis- that justify the issuance of the order; branding provisions under 21 U. If prior written approval is or locality, in accordance with the fol- not feasible, prior oral approval shall lowing procedures: be obtained and confirmed by written (A) Order for relabeling, diversion, or memorandum as soon as possible. I (4–1–10 Edition) (ii) Move them to another location mitted in connection with the hearing for holding pending appeal. Appearance by the order, and the name of the govern- any appellant at the hearing may be by ment representative who issued the mail or in person, with or without order. The party requesting the 5-working days of the issuance of the hearing may then present oral or writ- order. If the appeal includes a request ten information relevant to the hear- for an informal hearing, the hearing ing. All parties may conduct reason- shall be held within 5-working days able examination of any person (except after the appeal is filed or, if requested for the presiding officer and counsel for by the appellant, at a later date, which the parties) who makes any statement shall not be later than 20-calendar days on the matter at the hearing. The (3) The hearing shall be informal in order may also be appealed within the nature, and the rules of evidence do not same period of 5-working days by any apply. No motions or objections relat- other person having an ownership or ing to the admissibility of information proprietary interest in such shell eggs. All written material such eggs fails to relabel, divert, or de- presented at the hearing will be at- stroy them within 10-working days, the tached to the report. I (4–1–10 Edition) (c) Among representations in the la- name; and from which no portion of beling of a food which render such food any volatile oil or other flavoring prin- misbranded is any representation that ciple has been removed. Spices include expresses or implies a geographical ori- the spices listed in §182. A trademark or trade Rosemary, Saffron, Sage, Savory, Star ani- seed, Tarragon, Thyme, Turmeric. Natural fla- Requirements vors include the natural essence or ex- tractives obtained from plants listed in §101. Artificial flavor includes the spices, or oils extracted from spices, substances listed in §§172. The specific one of these regulations, and any non- artificial color used in a food shall be flavor ingredient, shall be separately identified on the labeling when so re- listed on the label. In cases where the tion 403(k) of the act if it is not in flavor contains both a natural flavor package form and the units thereof are and an artificial flavor, the flavor shall so small that a statement of artificial be so labeled, e. In cases where ical preservative, as the case may be, the flavor contains a solely artificial cannot be placed on such units with flavor(s), the flavor shall be so labeled, such conspicuousness as to render it e. I (4–1–10 Edition) smoked or has a true smoked flavor, or (ii) If none of the natural flavor used that a seasoning sauce or similar prod- in the food is derived from the product uct containing pyroligneous acid or whose flavor is simulated, the food in other artificial smoke flavor and used which the flavor is used shall be la- to season or flavor other foods will re- beled either with the flavor of the prod- sult in a smoked product or one having uct from which the flavor is derived or a true smoked flavor. A flavor user to certify that relevant inventories shall be required to make such a writ- have not been materially disturbed and ten certification only where he adds to relevant records have not been altered or combines another flavor with a fla- or concealed during such period. The examination conducted by quest at all reasonable hours to any the Secretary’s representative shall be duly authorized office or employee of limited to inspection and review of in- the Food and Drug Administration or ventories and ingredient records for any other employee acting on behalf of those certifications which are to be the Secretary of Health and Human verified. Such certifications are re- (v) Review of flavor ingredient garded by the Food and Drug Adminis- records shall be limited to the quali- tration as reports to the government tative formula and shall not include and as guarantees or other under- the quantitative formula. The person takings within the meaning of section verifying the certifications may make 301(h) of the act and subject the certi- only such notes as are necessary to en- fying party to the penalties for making able him to verify such certification. I (4–1–10 Edition) such certification or to show a poten- color additive has been used in the tial or actual violation may be re- food). Alternatively, such color addi- moved or transmitted from the certi- tives may be declared as "Colored with fying party’s place of business: Pro- lll" or "lll color", the blank to vided, That, where such removal or be filled with the name of the color ad- transmittal is necessary for such pur- ditive listed in the applicable regula- poses the relevant records and notes tion in part 73 of this chapter. Voluntary dec- (j) A food to which a chemical pre- laration of all colorings added to but- servative(s) is added shall, except when ter, cheese, and ice cream, however, is exempt pursuant to §101. For (k) The label of a food to which any the convenience of the user, the revised text coloring has been added shall declare is set forth as follows: the coloring in the statement of ingre- §101. Color," "Artificial Color Added," or "Color (1) A color additive or the lake of a Added" (or by an equally informative term color additive subject to certification that makes clear that a color additive has under 721(c) of the act shall be declared been used in the food). Alternatively, such color additives may be declared as "Colored by the name of the color additive listed with llllllll" or "llllllll in the applicable regulation in part 74 color," the blank to be filled in with the or part 82 of this chapter, except that name of the color additive listed in the ap- it is not necessary to include the plicable regulation in part 73 of this chapter. Manufacturers may for foods purporting to be bev- parenthetically declare an appropriate erages that contain fruit or vege- alternative name of the certified color table juice. Alternatively, the label percent juice" or "less than 1 percent may declare "Containing (or contains) lll juice" with the blank filled in no lll juice", or "no lll juice", or with the name of the particular fruit or "does not contain lll juice", the vegetable. I (4–1–10 Edition) name, logo, or universal product code; 100 and Juice percent juice1 (2) In easily legible boldface print or type in distinct contrast to other Guava........................................................................ Any (b)(2)-dietary ingredients tion labeling in accordance with this that are not present, or that are regulation unless an exemption is pro- present in amounts that can be de- vided for the product in paragraph (h) clared as zero in §101. Protein shall not shall contain the following informa- be declared on labels of products that, tion, using the subheadings and the other than ingredients added solely for format specified in paragraph (e) of technological reasons, contain only in- this section. Serving size for die- column, the heading may be centered tary supplements shall be expressed over a column of quantitative using a term that is appropriate for the amounts, described by paragraph form of the supplement, such as "tab- (b)(2)(ii) of this section, if space per- lets," "capsules," "packets," or "tea- mits. I (4–1–10 Edition) Other appropriate terms, such as cap- parentheses following the percent sule, packet, or teaspoonful, also may statement (e. The quantitative amounts by for vitamins and minerals: Vitamin A, weight shall represent the weight of vitamin C, vitamin D, vitamin E, vita- the dietary ingredient rather than the min K, thiamin, riboflavin, niacin, vi- tamin B , folate, vitamin B biotin, weight of the source of the dietary in- 6 12, pantothenic acid, calcium, iron, phos- gredient (e. When urement and the levels of significance "Calories from fat" or "Calories from given in §101. The quantitative lactating women, for total fat, satu- amount by weight of each dietary in- rated fat, cholesterol, total carbo- gredient in this calculation shall be the hydrate, dietary fiber, vitamin K, sele- unrounded amount, except that for nium, manganese, chromium, molyb- total fat, saturated fat, cholesterol, so- denum, chloride, sodium, or potassium, dium, potassium, total carbohydrate, a symbol (e. The symbol that is placed at the bottom of numerical value shall be followed by the nutrition label, below the last the symbol for percent (i. When there are no other titative amount of the dietary ingre- (b)(2)-dietary ingredients listed for dient by weight is great enough to re- which a value must be declared in the quire that the dietary ingredient be "% Daily Value" column, the column listed, but the amount is so small that may be omitted as shown in paragraph the "% Daily Value" when rounded to (e)(10)(vii) of this section. Where the name of the this section (hereinafter referred to as solvent used is not included in the nu- "other dietary ingredients") shall be trition label, it is required to be listed declared by their common or usual in the ingredient statement in accord- name when they are present in a die- ance with §101. When the weight per serving of other dietary in- constituents of a dietary ingredient de- gredients shall be presented in the scribed in paragraph (b)(3)(i) of this same manner as the corresponding in- section are listed, all other dietary in- formation required in paragraph gredients shall be declared in a col- (b)(2)(ii) of this section or, when a lin- umn; however, the constituents them- ear display is used, shall be presented selves may be declared in a column or immediately following the name of the in a linear display. The quan- titative amount by weight shall be the (iv) Other dietary ingredients shall weight of the other dietary ingredient bear a symbol (e. Information on the of dietary ingredients described in condition of the starting material shall paragraph (b)(3)(i) of this section and be indicated when it is fresh and may identified by the term "Proprietary be indicated when it is dried. Informa- Blend" or other appropriately descrip- tion may be included on the concentra- tive term or fanciful name and may be tion of the dietary ingredient and the highlighted by bold type. The title and all headings shall be (d) The source ingredient that sup- bolded to distinguish them from other plies a dietary ingredient may be iden- information. When a source ingredient is (iii) Upper- and lowercase letters, ex- identified in parentheses within the nu- cept that all uppercase lettering may trition label, or when the name of the be utilized for packages that have a dietary ingredient or its synonym is total surface area available to bear la- the source ingredient, it shall not be beling of less than 12 square inches, required to be listed again in the ingre- (iv) At least one point leading (i. I (4–1–10 Edition) paragraph (i)(2) of this section, infor- tion and be clearly identified by appro- mation other than the title, headings, priate headings. Type size tion is made in other parts of the label no smaller than 6 point may be used for that a dietary supplement be consumed column headings (e.
The Trace Elements in Water and Wastes availability of this incorporation by by Inductively Coupled Plasma-Mass reference is given in paragraph Spectrometry purchase 0.25mg cabergoline with mastercard menopause emotions," Rev purchase 0.25 mg cabergoline with visa women's health clinic orlando. The revision is con- (7) Cyanide shall be measured using tained in the manual entitled "Meth- the following methods: ods for the Determination of Metals in (i) Method 335 buy cabergoline 0.25 mg online breast cancer watch. The availability of this in- Spectrophotometric" which is incor- corporation by reference is given in porated by reference in accordance paragraph (b)(4)(iii)(E)(1)(ii) of this sec- with 5 U effective 0.25mg cabergoline womens health queensbury ny. The revision is availability of these incorporation by contained in the manual entitled reference is given in paragraph "Methods for the Determination of (b)(4)(iii)(E) of this section. I (4–1–10 Edition) (9) Mercury shall be measured using paragraph (b)(4)(iii)(E)(1)(ii) of this sec- the following methods: tion. The revision is vapor technique," which is incor- contained in the manual entitled porated by reference in accordance "Methods for the Determination of with 5 U. The revision is con- both nitrate and nitrite, which is in- tained in the manual entitled "Meth- corporated by reference in accordance ods for the Determination of Metals in with 5 U. Copies of this porated by reference in accordance publication are available from the Na- with 5 U. For Products in Water by Microextraction information on the availability of this and Gas Chromatography," Rev. The availability of these hexachlorobenzene, hexachlorocyclo- incorporation by reference is given in pentadiene, and simazine), which is in- paragraph (b)(4)(iii)(F) of this section. I (4–1–10 Edition) Water and Wastes," which is incor- Metals in Environmental Samples," Of- porated by reference in accordance fice of Research and Development, with 5 U. The (1) Aluminum shall be measured availability of this incorporation by using the following methods: reference is given in paragraph (i) Method 202. The revi- Trace Elements in Water and Wastes sion is contained in the manual enti- by Inductively Coupled Plasma-Atomic tled "Methods for the Determination of Emission Spectrometry," Rev. The revision is con- Trace Elements in Water and Wastes tained in the manual entitled "Meth- by Inductively Coupled Plasma-Mass ods for the Determination of Metals in Spectrometry," Rev. The revision is Trace Elements by Stabilized Tempera- contained in the manual entitled ture Graphite Furnace Atomic Absorp- "Methods for the Determination of tion Spectrometry," Rev. The revision is this section and described in "Method contained in the manual entitled 300. The availability of this in- ety for Testing and Materials, 1996, corporation by reference is given in which are incorporated by reference in paragraph (b)(4)(iii)(E)(11)(i) of this sec- accordance with 5 U. The availability of these 118 are also available from the Chem- incorporation by reference is given in ical Exposure Research Branch, Micro- paragraph (b)(4)(iii)(E) of this section. Copies of "Standard Substance Concentration in Methods for the Examination of Water milligrams per liter and Wastewater," 19th Ed. The revision is con- (1) Bromate shall be measured using tained in the manual entitled "Meth- the following method: Method 300. The ability of this incorporation by ref- availability of this incorporation by erence is given in paragraph reference is given in paragraph (b)(4)(iii)(I) of this section. The avail- the following methods: ability of this incorporation by ref- (i) Method 502. The avail- following methods: ability of this incorporation by ref- (i) Method 552. Pesticides/Herbicides in Drinking (v) Method 4500-Cl E—"Low-Level Water by Liquid-Liquid Extraction and Amperometric Titration Method," Gas Chromatography with Electron- which is contained in the book entitled Capture Detection," Rev. The revi- "Standard Methods for the Examina- sion is contained in the manual enti- tion of Water and Wastewater," 19th tled "Methods for the Determination of Ed. Methods for the Examination of Water (5) Compliance with the chloramine and Wastewater," 19th Ed. The availability of this in- metric Titration Method," which is corporation by reference is given in contained in the book entitled "Stand- paragraph (b)(4)(iii)(I) of this section. The availability of this in- cluding radium-226, but excluding corporation by reference is given in radon and uranium) in excess of 15 paragraph (b)(4)(iii)(I) of this section. If two or more beta or by reference is given in paragraph photon-emitting radionuclides are (b)(4)(iii)(I) of this section. The availability of this in- compliance with the requirements of corporation by reference is given in paragraph (b)(5)(i) of this section shall paragraph (b)(4)(iii)(I) of this section. The avail- tained from the American Public ability of this incorporation by ref- Health Association, 1015 15th St. The corporation by reference is given in the availability of this incorporation by introductory text of paragraph (b)(5)(ii) reference is given in the introductory of this section. Precipitation Method," which is con- (D) Uranium shall be measured using tained in "Standard Methods for the the following methods: Examination of Water and Waste- water," 20th Ed. The "Standard Methods for the Examina- availability of this incorporation by tion of Water and Wastewater," 20th reference is given in the introductory Ed. The availability of this in- (B) Gross alpha particle radioactivity corporation by reference is given in the shall be measured using the following introductory text of paragraph (b)(5)(ii) method: Method 7110 C—"Coprecipita- of this section. The The availability of this incorporation availability of this incorporation by by reference is given in the introduc- reference is given in the introductory tory text of paragraph (b)(5)(ii) of this text of paragraph (b)(5)(ii) of this sec- section. When the micro- (C) Beta particle and photon radioac- biological, physical, chemical, or radio- tivity shall be measured using the fol- logical quality of bottled water is lowing methods: below that prescribed by paragraphs (1) Method 7500–Sr B—"Precipitation (b)(2) through (b)(5), of this section, the Method," which is contained in label shall bear the statement of sub- "Standard Methods for the Examina- standard quality specified in §130. Subpart A—General Provisions (2) "Excessively Turbid", "Abnormal Color", and/or "Abnormal Odor" if the §166. It provides that these re- bottled water fails to meet the require- quirements "shall be in addition to and ments of paragraph (b)(5) of this sec- not in lieu of any of the other require- tion. Bottled water con- (a) Under section 403(g) of the Fed- taining a substance at a level consid- eral Food, Drug, and Cosmetic Act, any ered injurious to health under section article that is represented as or pur- 402(a)(1) of the Federal Food, Drug, and ports to be oleomargarine or margarine Cosmetic Act (the act), or that consists must conform to the definition and in whole or in part of any filthy, pu- standard of identity for oleomargarine trid, or decomposed substance, or that or margarine promulgated under sec- is otherwise unfit for food under sec- tion 401 of the act (Subpart B of this tion 402(a)(3) of the act is deemed to be part), and its label must bear the name adulterated, regardless of whether or "oleomargarine" or "margarine". The word "Individual" may be made in imitation or semblance of but- used in lieu of or immediately pre- ter". Notwithstanding the difference ceding the word "Retail" in the state- between this definition and the defini- ment. Margarine (or oleo- though it may meet the statutory defi- margarine) is the food in plastic form nition. I (4–1–10 Edition) 202–741–6030, or go to: http:// less than 15,000 international units per www. Margarine contains in such quantity that the finished oleo- only safe and suitable ingredients, as margarine contains not less than 1,500 defined in §130. It is international units of vitamin D per produced from one or more of the op- pound. For the purpose of this subparagraph, provitamin A (beta- (2) One or more of the following aque- carotene) shall be deemed to be a color ous phase ingredients: additive. The name of the than reasonably required to accomplish food for which a definition and stand- the desired effect. Each of the in- (iv) The ingredients in paragraphs gredients used in the food shall be de- (a)(2) (i), (ii), and (iii) of this section clared on the label as required by the shall be pasteurized and then may be applicable sections of parts 101 and 130 subjected to the action of harmless of this chapter. One or more of the this section the use of the term "milk" articles designated in paragraphs (a)(2) unqualified means milk from cows. If (i), (ii), and (iii) of this section is inti- any milk other than cow’s milk is used mately mixed with the edible fat and/or in whole or in part, the animal source ingredients to form a solidified or liq- shall be identified in conjunction with uid emulsion. Subpart B—Requirements for Specific (c) The name of the food is "Dextrose Standardized Sweeteners and Table Sirups monohydrate" or "Dextrose" or alter- natively, "lll sugar monohydrate" Sec. I (4–1–10 Edition) (b) The food shall meet the following partially removed and conforms to the specifications: specifications of §168. For example, "Corn sirup", specific type of starch, the name may "Wheat sirup", "Tapioca sirup". When alternatively be "Dried lll sirup" or the starch is derived from sorghum "lll sirup solids", the blank to be grain, the alternative name of the food filled in with the name of the starch; is "Sorghum grain sirup". The word for example, "Dried corn sirup", "Corn "sirup" may also be spelled "syrup".
9 of 10 - Review by N. Nefarius
Votes: 176 votes
Total customer reviews: 176